Address
1 Avenue d'Ester - 87280 LIMOGES
Email
info@curlim.eu
We’re pleased to announce that Laurent Richebourg, CEO of CURLIM will be participating in BioEquity Europe 2026 and presenting CURLIM , in Prague from May 4–6.
BioEquity is one of Europe’s leading investor conferences, bringing together biotech companies, investors, and strategic partners to explore the most promising innovations in life sciences.
This year, we will be sharing our latest progress and development strategy for CLM001 our nanomedicine candidate, targeting the root mechanisms of Charcot-Marie-Tooth disease type 1A (CMT1A)
We will also be available for one-to-one meetings throughout the event to engage with investors and partners interested in rare diseases, nanomedicine, and early-stage biotech opportunities.
📩 If you’ll be in Prague, let’s connect.
Reach out to schedule a meeting or connect via the partnering platform.